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Anergy and relative anergy have been associated with malnutrition, sepsis, and shock, and treatment of these underlying conditions has resulted in increased skin testing reactivity. â€˜¿ Complications of surgery such as abscess formation and pneumonia have also been associated with anergic response on DHSTs.2 The situation of the heart transplant recipient is of partic ular interest because cardiac rejection may be largely due to delayed hypersensitivity and the release of cytokines such as tumor necrosis factor beta, inter feron gamma, and other cytokines released by stimu lated lymphocytes.3 Therefore, the results of previous studies suggest that decreased cellular immunity may place patients at risk for sepsis and pneumonia, whereas increased cellular reactivity may enhance rejections. We set out to establish the prognostic value of DHSTs in establishing the clinical course of heart transplant recipients.
MATERIALS AND METHODS
A retrospective study of the cardiac transplant population be The 127 patients studied included 98 male and 29 female patients. There were 113 white and 14 non white subjects. Sixty-one patients had cardiomyopathy as their primary heart disease, 53 patients had coro nary artery disease, and 13 patients had valvular or congenital heart disease. The anergic and reactive groups were similar with respect to the characteristics described previously and also their ages at transplant, ejection fraction, and laboratory values such as alkaline phosphatase, glucose, creatinine, and hematocrit (Ta ble 1). The levels of albumin and total protein were significantly lower in the anergic group, and the total bilirubin level was significantly higher in this group.
The mortality at 30, 60, and 90 days after surgery was significantly increased in the anergic group ( Fig   1) . That difference was not significant for long-term postoperative survival, although long-term survival was worse for anergic patients (Fig 2) . 37 Rates of postoperative infection were similar be 90 tween the two groups ( Table  2 ). There were no 21 significant differences in the overall rate of infection 31 or in the rate of infections of the heart; central nervous system; ear, nose, and throat (ENT); gastrointestinal (GI) tract; or skin. The anergic group had a slightly higher rate of pulmonary infections. The organisms in infections within 6 months after surgery are shown in Table 3 . The rate of moderate or severe graft rejection was significantly lower in the anergic group at 7 days after surgery (6 percent, compared with 28 percent in the reactive group; p 0.007); the difference in rejection rates was not significant at 30, 60, and 90 days (Fig 3) . At the time of the study, 13 (35 percent) of the 37 anergic patients had died, and 19 (21 percent) of the 90 reactive patients had died . The contributing causes ofdeath among these 32 patients were compared, and no significant differences between the 2 groups were found (Table 4) .
DISCUSSION
We studied a unique group of patients with end stage cardiac disease before surgery with DHSTs. Our results suggest that allergic results on DHSTs before surgery are associated with higher mortality at 30, 60, and 90 days after surgery. We propose that DHSTs be performed before organ transplantation as a prognostic indicator for postoperative mortality. This is a simple and inexpensive test.
Interestingly, there was 110increased morbidity in our anergic group after surgery, in contrast to previ * ously published studies,' 2,8II)however, these studies were of presurgical patients, not pretransplant pa tients. Possible explanations for the lack of differences in morbidity between our two groups are as follows:
( 1) maybe anergy is unimportant for the occurrence of morbidity; (2) our rate of morbidity is excessive in both groups or very small in both groups; and (3) (Tables 2 and 3) . Twenty-six patients developed infec tions. There were no significant differences in the organisms causing postoperative infections or in the organ of infectious involvement between the two groups. Pulmonary infections were more common in anergic patients than in reactive patients. Seventy eight percent (7 of 9) of the infected anergic patients had pulmonary infections, compared with 41 percent (7 of 17) in the reactive group. The biggest difference was in the rate of pneumonia, which was 67 percent (6 of 9) in the anergic group versus 24 percent (4 of 17) in the reactive group. While these differences are not statistically significant in this small sample, the numbers are somewhat suggestive of a possible rela tionship between anergy and postoperative pneumo nia. Both groups had a similar incidence of patients who became infected with organisms typically associated with deficient T cell immunity such as Aspergillus fumigatus, Pneumocystis carinii, Mycobacterium tu berculosis, Candida albicans, and cytomegalovirus. Therefore, anergy did not predict the specific type of infection that these patients contracted. Our numbers and results would have been strengthened by a larger number of patients in our series.
A study assessing 200 patients with nutritional deficiencies with DHSTs in 1988 reported that anergic patients had a threefold increase in mortality and an 80 percent increase in major sepsis.â€• Age and gender were not factors in producing anergy in our study, as has been previously reported.2 As in the study by MacLean et al,@the serum albumin level (while in the normal range) in our anergic patients was significantly lower than in the reactive patients. This may be attributed to lowered nutritional status within the anergic group. This relationship between poor nutri tional status and anergy has been demonstrated be fore. 12 In the 32 patients who died, an analysis of the causes of death was performed (Table 4 ). Sixteen of these 32 patients died because of rejection episodes; the differences were not significant between the groups. This is consistent with our finding that the reactive group had a higher rejection rate immediately after surgery, but not later.
Six patients died of septic complications (two anergic
and four reactive). The two anergic patients had generalized viral infection and fungal pulmonary in fection as their primary cause of death. The differences were insignificant; anergy did not increase a patient's chance of death due to sepsis. We could not find significant differences in the cause of death between the two groups. Forse et alt2 described a large population of patients who, when aggressively treated with parenteral nutri tion, clinically improved and converted to reactive upon repeat skin testing, with a much lower mortality than the anergic group of patients, who were not aggressively treated and did not convert. Laboratory values associated with deficient nutritional status such as lowered levels of albumin and total protein may predict this early increased mortality of the anergic patient. Malnutrition results in impairment of the immune system, but measurement of anergy better predicts clinical risk than measurements of malnutri tion (eg, albumin level, body cell mass, and protein level). The parameters of malnutrition could be normal in a patient with in vivo absence of cell-mediated immunity.
Our population of patients with cardiac cachexia may not respond to total parenteral nutrition, unlike patients with cachexia secondary to malnutrition. The limiting factor in our patients is one of decreased cardiac output, resulting in inadequate delivery of protein, calories, and fat to tissues.
The anergic patients had a lower T cell response to antigens and perhaps a lower subsequent incidence of rejection at 7 days after surgery because of their lower T cell response. Organ transplant rejection involves T cells and cell-mediated immunity. Therefore, it ap pears logical that the reactive group with an intact T cell response may have a higher rate of organ rejection 1 week after transplantation. One study'3 used a mouse model that showed that the T cells responsible for delayed hypersensitivity differentiated earlier and more quickly after immunosuppression and bone marrow transplant. One possible explanation for the increased incidence of rejection at 7 days after trans plantation in the reactive group is their increase in responsive T cells. The anergic group may have been capable of recruiting enough T cells by 14 days to match the rejection rate of the reactive group. At 30, 60, and 90 days after surgery, the rejection rates did not differ significantly in the two groups, possibly because the anergic patients had an opportunity to recover from their cachectic state, with their newly transplanted hearts being more efficient at delivering nutrients to end organs. This recovery would be expected to increase immune function and lead to restoration of normal T cell activities.
The question is: should anergic patients be treated differently with either additional nutrition before transplantation or reduced immunosuppression after transplantation?
Total parenteral nutrition will not benefit the anergic patient, since this population with cardiac cachexia cannot deliver the metabolites to end organs. We are considering a lowered dose of immu nosuppressive drugs (eg, prednisone) in the anergic patient after cardiac transplantation.
A definitive course of action will have to await future studies on DHSTs and the transplant recipient.
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